fluorouracil has been researched along with nutlin-3a in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Abolmaali, ND; Tokalov, SV | 1 |
Abei, M; Endo, S; Fukuda, K; Hirai, S; Hyodo, I; Moriwaki, T; Nakagawa, I; Suzuki, H; Yamato, K | 1 |
Bisio, A; Ciribilli, Y; De Sanctis, V; Inga, A; Lion, M; Menendez, D; Resnick, MA; Tebaldi, T | 1 |
Iimori, M; Kadomatsu, K; Kitao, H; Kiyonari, S; Maehara, Y; Matsuoka, K; Miura, D; Morikawa-Ichinose, T; Morita, M; Niimi, S; Oki, E; Saeki, H; Tokunaga, E; Watanabe, S | 1 |
Abraham, BJ; Amat, R; Fisher, RP; Gray, NS; Kalan, S; Kwiatkowski, N; Larochelle, S; Liang, Y; Olson, CM; Schachter, MM; Young, RA; Zhang, T | 1 |
Dowell, RD; Gruca, M; Jones, T; Levandowski, CB; Ramamoorthy, S; Taatjes, DJ | 1 |
6 other study(ies) available for fluorouracil and nutlin-3a
Article | Year |
---|---|
Protection of p53 wild type cells from taxol by nutlin-3 in the combined lung cancer treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Camptothecin; Cell Line, Tumor; Drug Screening Assays, Antitumor; Flow Cytometry; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Lung Neoplasms; Models, Genetic; Mutation; Piperazines; Purines; Roscovitine; Tumor Suppressor Protein p53 | 2010 |
Potent in vitro and in vivo antitumor effects of MDM2 inhibitor nutlin-3 in gastric cancer cells.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cisplatin; Cyclin-Dependent Kinase Inhibitor p21; Female; Fluorouracil; Gene Dosage; Humans; Imidazoles; Mice; Mice, Inbred BALB C; Nuclear Proteins; Piperazines; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Stomach Neoplasms; Tumor Suppressor Protein p53 | 2011 |
Interaction between p53 and estradiol pathways in transcriptional responses to chemotherapeutics.
Topics: Blotting, Western; Doxorubicin; Estradiol; Fluorouracil; Gene Expression Profiling; Gene Expression Regulation; Humans; Imidazoles; MCF-7 Cells; Microarray Analysis; Piperazines; Real-Time Polymerase Chain Reaction; Time Factors; Transcription, Genetic; Tumor Suppressor Protein p53 | 2013 |
The 1,2-Diaminocyclohexane Carrier Ligand in Oxaliplatin Induces p53-Dependent Transcriptional Repression of Factors Involved in Thymidylate Biosynthesis.
Topics: Biosynthetic Pathways; DNA Replication; Down-Regulation; Drug Synergism; E2F1 Transcription Factor; E2F3 Transcription Factor; Fluorouracil; Gene Expression Regulation, Neoplastic; Gene Silencing; HCT116 Cells; Humans; Imidazoles; MicroRNAs; Organoplatinum Compounds; Oxaliplatin; Piperazines; Pyrophosphatases; Sp1 Transcription Factor; Thymidine Monophosphate; Transcription, Genetic; Tumor Suppressor Protein p53 | 2015 |
Activation of the p53 Transcriptional Program Sensitizes Cancer Cells to Cdk7 Inhibitors.
Topics: Antineoplastic Agents; Apoptosis; Cyclin-Dependent Kinase-Activating Kinase; Cyclin-Dependent Kinases; Drug Resistance, Neoplasm; Fluorouracil; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Imidazoles; Phenylenediamines; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Transcriptional Activation; Tumor Suppressor Protein p53 | 2017 |
The Δ40p53 isoform inhibits p53-dependent eRNA transcription and enables regulation by signal-specific transcription factors during p53 activation.
Topics: Cell Line; Fluorouracil; Genes, p53; Humans; Imidazoles; Piperazines; Protein Isoforms; Protein Structure, Quaternary; Transcription Factors; Transcription, Genetic; Transcriptome; Tumor Suppressor Protein p53 | 2021 |